internal carotid artery (ICA) and degree of carotid stenosis using Doppler ultrasound.Methods: Patients (n ¼ 30) with suspected or previously diagnosed carotid stenosis underwent duplex ultrasounds using a Philips iU22 ultrasound module and a 9-3 MHz probe. A total of 34 carotid studies were analyzed, of which 19 were diseased and 15 were normal. Color Doppler cine loops of the internal carotid artery were recorded and analyzed off-line using customized algorithms written in IDL, a data visualization programming language. The Doppler flow at individual pixels in the image was used to calculate the area of reverse flow (% ARF), reverse mean velocity (RMV), and turbulent flow volume (TFV ¼ %ARF Â RMV).Results: The TFV correlated with percent stenosis. Diseased ICAs have significantly higher TFV than normal ICAs (P ¼ .0038 by two-tailed t-test; Fig, A). In addition, the post-stenotic TFV correlated with peak systolic velocity (R ¼ 0.47) in the ICA (Fig, B).Conclusions: Duplex imaging and easily implemented computerized image analysis can measure carotid turbulence. These measures correlate with PSV and segregate between normal and diseased carotid arteries in human subjects. This turbulence imaging may allow risk stratification (respective to stroke) of patients with asymptomatic carotid stenosis and may better predict progression of disease. A larger study in patients with both asymptomatic and symptomatic disease is underway and will elucidate the utility of this imaging technique.
Procedures to enhance aortic remodeling in the setting of an acute aortic dissection have been described. The authors have extended techniques in the chronic setting and include the abdominal aorta.
Objectives: Pelvic arteriovenous malformations (AVMs) are rare, complex clinical entities that often require a multifaceted approach to treatment. Surgical ligation of proximal feeding vessels has historically been shown to result in recurrence, and thus endovascular embolization is now the mainstay of treatment. The purpose of this study was to review the outcomes of a large series of patients with pelvic AVMs managed using a variety of endovascular techniques.Methods: We retrospectively reviewed all patients with high-flow pelvic AVMs treated at our institution from January 2005 to December 2015. Patient-related data were collected with regard to patient demographics, comorbidities, and presenting symptoms. Procedural and anatomic information, including embolization agent and vessel(s) treated, was collected, as well as follow-up data regarding number of treatments required and resolution of symptoms.Results: A total of 30 patients, 17 female (56.6%), with a mean age of 52.1 years (range, 28-89 years), underwent treatment for pelvic AVMs at our institution. Presenting symptoms included pelvic pain and discomfort in 25 patients (83.3%), bleeding in 8 (26.7%), high output cardiac failure in 7 (23.3%), mass effect in 5 (16.7%), and hematuria in 3 (10%). A total of 121 procedures were performed, with a mean of four procedures per patient (range, 1-13 procedures). Multiple procedures were performed in 23 patients (76.7%), 10 (33.3%) of which were planned as staged embolizations. The most common vessels involved were branches of the hypogastric artery in 27 patients (90.8%). Other vessels included inferior mesenteric artery branches in 6 patients (30%), median sacral artery in 3 (10%), and gonadal artery in 2 (6.7%). Multiple arteries were involved in Author Disclosures: Z. Cheema: Nothing to disclose; C. Cheng: W. L. Gore: other financial or material support; G. Fankhauser: Nothing to disclose; M. Silva: Nothing to disclose; J. Worsham: Nothing to disclose.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.